Form 4 for AXGN Axogen, Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0000805928-22-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-17 | 2022-02-15 | AXGN | Zaderej Karen L. | CEO, Dir | A - Grant | $0.00 | +14.0K | 940.4K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | A | A | 13,978 | $0.00 | 940,383 | D | — | — | (F1) This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria. (F2) Includes 728 shares acquired under the Axogen stock purchase plan on December 31, 2021. |